Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
Clinical trial NCT03925246 · COMPLETED
Trial details
- NCT number
- NCT03925246
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2020-12-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.